MEK Inhibitors

COBIMETINIB treats skin cancer. It may also be used to treat blood and bone marrow cancers. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

Gomekli is part of the MEK Inhibitors class and treats Neurofibromatosis. MEK (mitogen activated protein kinase) inhibitors are used to treat certain types of cancers such as melanoma and lung cancer as well as neurofibromatosis. MEK inhibitors work by slowing tumor cell growth to prevent the spread of disease. Gomekli is only available as a brand name drug.

SELUMETINIB treats neurofibromatosis, a condition that causes tumors to grow along the nerves. It works by blocking a protein that causes tumor cells to grow and multiply.

TRAMETINIB treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

BINIMETINIB treats skin cancer and lung cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.